Journals / Turkish Journal of Internal Medicine / 2022 / Cilt: 4 - Sayı: 1

Five Years’ Experience of Multidisciplinary Approach to Chronic Inflammatory Diseases by Rheumatology, Dermatology and Gastroenterology Departments

Pages
37–44
Publication Date
2022-01-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study, we aimed to emphasize the increasing importance of such multidisciplinary approaches

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Chronic inflammatory diseases (CIDs) are lifelong complex disorders that affect quality of life, and this study aimed to summarize 5 years of experience with a multidisciplinary approach for these complex diseases as a result of medical council meetings.
📊
Key Findings & Data:A total of 45 monthly medical council meetings were held between 2014-2019 with the participation of the rheumatology, dermatology and gastroenterology departments of the same university.
💡
Conclusion & Impact:In this study, we aimed to emphasize the increasing importance of such multidisciplinary approaches
🔬Design:Review & Systematic Survey
📍Scope:2014-2019 Verileri
⚙️Variables:Chronic inflammatory diseases · dermatology · gastroenterology

Abstract

Introduction: Chronic inflammatory diseases (CIDs) are lifelong complex disorders that affect quality of life, and this study aimed to summarize 5 years of experience with a multidisciplinary approach for these complex diseases as a result of medical council meetings. Methods: Hospital-based, medical records review study was conducted. A total of 45 monthly medical council meetings were held between 2014-2019 with the participation of the rheumatology, dermatology and gastroenterology departments of the same university. Patients with complex conditions that were seen in each department's own polyclinic composed the council. This study only included 308 patients referred by the rheumatology group. Results: Females made up 66.5 % of the 308 patients. The median age was 45 (19-77). PsA (psoriatic arthritis) and other SPA (spondyloarthritis) patients composed 49.3% of the total. A total of 68.18% of the patients were presented only to consult with the dermatology department. The most common reason for presenting patients was to discuss options for treatment (41.5%). The diagnosis of psoriasis was confirmed in 48 of 67 (71.6%) patients who presented with a pre-diagnosis. The diagnosis was changed in 34.74% of the patients, whereas the diagnosis became completely different in 11.36% of the patients. Conclusions: Many patients with challenging diagnosis and treatment processes are encountered in daily practice. The combination of different disciplines makes it possible to provide more rapid and effective solutions. In this study, we aimed to emphasize the increasing importance of such multidisciplinary approaches

🔖

Cite This Article

YAĞIZ, B., COŞKUN, B. N., OCAK, T., GÜNER, A., MACUNLUOGLU, A., PEHLİVAN, Y., KIYICI, M., YAZİCİ, S., BAŞKAN, E., DALKILIÇ, H. E. (2022). Five Years’ Experience of Multidisciplinary Approach to Chronic Inflammatory Diseases by Rheumatology, Dermatology and Gastroenterology Departments. Turkish Journal of Internal Medicine, Cilt: 4 - Sayı: 1, 37–44. https://ajindex.com/articles/809019

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Daniel C Baumgart, William J Sandborn. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369(9573):1641-57. doi:10.1016/S0140- 6736(07)60751-X. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Investig. 2007;117(3):514-21. doi: 10.1172/JCI30587. Andersen V, Holmskov U, Sørensen SB, Jawhara M, Andersen KW, Bygum A, et.al. A proposal for a study on treatment selection and lifestyle recommendations in chronic inflammatory diseases: A danish multidisciplinary collaboration on prognostic factors and personalized medicine. Nutrients. 2017 May 15;9(5):499. doi: 10.3390/nu9050499. Ibrahim G, Waxman R, Helliwell PS. The prevalence of psoriatic arthritis in people with psoriasis. Arthritis Rheum. 2009 Oct 15;61(10):1373-8. doi: 10.1002/ art.24608. Wilson FC, Icen M, Crowson CS, McEvoy MT, Gabriel SE, Kremers HM. Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: a populationbased study. Arthritis Rheum. 2009 Feb 15;61(2):233-9. doi: 10.1002/art.24172. Velez NF, Wei-Passanese EX, Husni ME, Mody EA, Qureshi AA. Management of psoriasis and psoriatic arthritis in a combined dermatology and rheumatology clinic. Arch Dermatol Res. 2012 Jan;304(1):7-13. doi:10.1007/s00403-011-1172-6.
  2. Gladman DD, Stafford-Brady F, Chang CH, Lewandowski K, Russell ML. Longitudinal study of clinical and radiological progression in psoriatic arthritis. J Rheumatol. 1990 Jun;17(6):809-12.
  3. Kane D, Stafford L, Bresnihan B, FitzGerald O. A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience. Rheumatology (Oxford). 2003 Dec;42(12):1460-8. doi: 10.1093/rheumatology/keg384. McHugh NJ, Balachrishnan C, Jones SM. Progression of peripheral joint disease in psoriatic arthritis: a 5-yr prospective study. Rheumatology (Oxford). 2003 Jun;42(6):778-83. doi: 10.1093/rheumatology/keg217. Hindryckx P, Novak G, Costanzo A, Danese S. Disease-related and drug-induced skin manifestations in inflammatory bowel disease. Expert Review of Gastroenterology and Hepatology. 2017;11(3):203-214. doi: 10.1080/17474124.2017.1283985. Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A, Emery P. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis. Rheumatology (Oxford). 2006 Aug;45(8):1029-38. doi:10.1093/rheumatology/kel147. Fowler JF, Duh MS, Rovba L, Butea